March 16 (Reuters) - CSPC Pharmaceutical Group Ltd :
* CANCER DRUG DEVELOPED BY WUHAN YZY BIOPHARMA GRANTED DRUG CLINICAL TRIAL APPROVAL BY CHINA FDA Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.